Advitech researches, develops, and commercializes nutraceutical ingredients and products to prevent immune-mediated inflammatory disorders.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Calgary
State: Alberta
Zip:
Country: Canada
Advitech is a life science and technology company with the mission to discover and commercialize patented, scientifically supported natural health products. Effective and safe, these products target immune system disorders, such as psoriasis and inflammatory bowel disease. Advitech produces Dermylex (R) for the treatment of mild to moderate psoriasis. Advitech has developed a research program to develop new applications in the field of wound healing. This development program stems from the two technological platforms XP-828L and IM.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2010 | Venture Round | 1 | $1.4M |
Avrio Capital Avrio Capital |
11/2009 | Venture Round | 3 | $2.5M |
AgeChem Venture Fund Avrio Capital Michael Stangel AgeChem Venture Fund Avrio Capital Michael Stangel |
---|
Announced Date | Name | Price |
---|---|---|
10/2011 | Natunola Health Biosciences Inc | |
11/2009 | Botaneco |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|